Regeneron Pharmaceuticals Inc. sell robertinio
Start price
20.04.20
/
50%
€534.90
Target price
01.05.20
-
Performance (%)
-9.33%
End price
01.05.20
€485.00
Summary
This prediction ended on 01.05.20 with a price of €485.00. With a performance of -9.33%, the SELL prediction for Regeneron Pharmaceuticals Inc. by robertinio was down slightly. robertinio has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.320% | 3.320% | -4.010% | 7.862% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by robertinio for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Sell Regeneron Pharmaceuticals Inc.